logo

Nektar Therapeutics (NKTR)



Trade NKTR now with
  Date
  Headline
5/31/2018 8:17:19 AM Nektar Therapeutics Announces Submission Of NDA To FDA For NKTR-181
5/30/2018 4:06:03 PM Syndax And Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
5/10/2018 4:11:46 PM Nektar Therapeutics Q1 Loss Per Share $0.60 Vs Loss $0.42 Last Year
5/8/2018 8:33:56 AM Nektar Therapeutics Begins Phase 1b Clinical Study Of NKTR-358
4/24/2018 8:32:05 AM Nektar Enter Clinical Collaboration With Takeda To Evaluate Combination Of NKTR-214 And TAK-659
4/11/2018 8:04:58 AM Nektar Therapeutics Begins Dosing Patients In Phase 1/2 REVEAL Clinical Study Of Combination Of NKTR-262 And NKTR-214